Intel Corporation (INTC) vs Eli Lilly and Company (LLY)
See how Intel Corporation and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$89.51
NasdaqGS
Intel Corp is a major semiconductor company that designs and manufactures microprocessors for the worldwide PC and data center markets. The company helped establish the x86 microprocessor architecture and played a central role in advancing Moore’s law through semiconductor manufacturing innovation. Intel continues to hold leading market share in central processing units for both personal computers and servers. The company is working to revitalize its chip manufacturing operations through Intel Foundry while developing advanced products within its Intel Products segment.
View Full Page$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full PageKey Metrics Comparison
Intel CorporationINTC
Market Cap$473.159B
Price$89.51
24h Change+0.04%
24h Volume$64.52M
Employees85,100
Shares Outstanding5,026,000,000
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
INTC
31.4%LLY
68.6%Volume Share
Share of combined 24h volume
INTC
95.5%LLY
4.5%24h Performance
Price change over last 24 hours
INTC
0.04%LLY
-1.52%Price Comparison
Intel Corporation
Eli Lilly and Company